• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化学神经科学中的黑暗经典:Δ-四氢大麻酚。

Dark Classics in Chemical Neuroscience: Δ-Tetrahydrocannabinol.

机构信息

Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre , The University of Sydney , Sydney , NSW 2050 , Australia.

Faculty of Science and School of Chemistry , The University of Sydney , Sydney , NSW 2006 , Australia.

出版信息

ACS Chem Neurosci. 2019 May 15;10(5):2160-2175. doi: 10.1021/acschemneuro.8b00651. Epub 2019 Feb 22.

DOI:10.1021/acschemneuro.8b00651
PMID:30689342
Abstract

Cannabis ( Cannabis sativa) is the most widely used illicit drug in the world, with an estimated 192 million users globally. The main psychoactive component of cannabis is (-)- trans-Δ-tetrahydrocannabinol (Δ-THC), a compound with a diverse range of pharmacological actions. The unique and distinctive intoxication caused by Δ-THC primarily reflects partial agonist action at central cannabinoid type 1 (CB) receptors. Δ-THC is an approved therapeutic treatment for a range of conditions, including chronic pain, chemotherapy-induced nausea and vomiting, and multiple sclerosis, and is being investigated in indications such as anorexia nervosa, agitation in dementia, and Tourette's syndrome. It is available as a regulated pharmaceutical in products such as Marinol, Sativex, and Namisol as well as in an ever-increasing range of unregistered medicinal and recreational cannabis products. While cannabis is an ancient medicament, contemporary use is embroiled in legal, scientific, and social controversy, much of which relates to the potential hazards and benefits of Δ-THC itself. Robust contemporary debate surrounds the therapeutic value of Δ-THC in different diseases, its capacity to produce psychosis and cognitive impairment, and the addictive and "gateway" potential of the drug. This review will provide a profile of the chemistry, pharmacology, and therapeutic uses of Δ-THC as well as the historical and societal import of this unique, distinctive, and ubiquitous psychoactive substance.

摘要

大麻(Cannabis sativa)是世界上使用最广泛的非法药物,全球估计有 1.92 亿使用者。大麻的主要精神活性成分是(-)-反式-Δ-四氢大麻酚(Δ-THC),这是一种具有广泛药理学作用的化合物。Δ-THC 引起的独特和独特的陶醉主要反映了其在中枢大麻素 1 型(CB1)受体上的部分激动剂作用。Δ-THC 已被批准用于治疗多种疾病,包括慢性疼痛、化疗引起的恶心和呕吐以及多发性硬化症,并且正在厌食症、痴呆症激越和图雷特氏综合征等适应症中进行研究。它作为一种受管制的药物,以 Marinol、Sativex 和 Namisol 等产品以及越来越多未经注册的药用和娱乐性大麻产品的形式出现。虽然大麻是一种古老的药物,但现代使用却陷入了法律、科学和社会争议之中,其中大部分与 Δ-THC 本身的潜在危害和益处有关。围绕 Δ-THC 在不同疾病中的治疗价值、它产生精神病和认知障碍的能力以及该药物的成瘾性和“门户”潜力,展开了激烈的当代辩论。本文将介绍 Δ-THC 的化学、药理学和治疗用途,以及这种独特、独特和无处不在的精神活性物质的历史和社会重要性。

相似文献

1
Dark Classics in Chemical Neuroscience: Δ-Tetrahydrocannabinol.化学神经科学中的黑暗经典:Δ-四氢大麻酚。
ACS Chem Neurosci. 2019 May 15;10(5):2160-2175. doi: 10.1021/acschemneuro.8b00651. Epub 2019 Feb 22.
2
Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.在欧洲,用于慢性疼痛管理和姑息/支持性治疗的基于大麻的药物的可及性和批准情况:对欧洲疼痛联合会各章节现状的调查。
Eur J Pain. 2018 Mar;22(3):440-454. doi: 10.1002/ejp.1147. Epub 2017 Nov 13.
3
Pharmacology of Medical Cannabis.医用大麻的药理学。
Adv Exp Med Biol. 2019;1162:151-165. doi: 10.1007/978-3-030-21737-2_8.
4
Cannabinoids for Treatment of MS Symptoms: State of the Evidence.大麻素治疗多发性硬化症症状:证据现状。
Curr Neurol Neurosci Rep. 2018 Jun 19;18(8):50. doi: 10.1007/s11910-018-0859-x.
5
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.临床使用大麻类药物治疗的数据:文献综述
Ann Pharmacother. 2020 Nov;54(11):1109-1143. doi: 10.1177/1060028020930189. Epub 2020 Jun 2.
6
Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.基于大麻类药物的医学用途、疗效及不良反应趋势,为医疗保健专业人员提供的医用大麻患者咨询要点。
Res Social Adm Pharm. 2016 Jul-Aug;12(4):638-54. doi: 10.1016/j.sapharm.2015.09.002. Epub 2015 Sep 16.
7
Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol.Delta-8-四氢大麻酚的化学与药理学
Molecules. 2024 Mar 11;29(6):1249. doi: 10.3390/molecules29061249.
8
Therapeutic issues of marijuana and THC (tetrahydrocannabinol).大麻和四氢大麻酚(THC)的治疗问题。
Int J Addict. 1985 May;20(5):691-9. doi: 10.3109/10826088509044289.
9
The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.一种新型便携式定量吸入式大麻吸入器用于慢性神经性疼痛患者的药代动力学、疗效、安全性及易用性:一项1a期研究
J Pain Palliat Care Pharmacother. 2014 Sep;28(3):216-25. doi: 10.3109/15360288.2014.941130. Epub 2014 Aug 13.
10
A randomised controlled trial of vaporised Δ-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.一项随机对照试验研究了在频繁和不频繁使用大麻的人群中单独使用和联合使用蒸气化 Δ-四氢大麻酚和大麻二酚的效果:急性中毒效应。
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2. Epub 2019 Jan 19.

引用本文的文献

1
Use of Medicinal Cannabis for Epilepsy in the Australian Community 2023-2024: A Cross-Sectional Survey.2023 - 2024年澳大利亚社区医用大麻用于癫痫治疗的情况:一项横断面调查
J Epilepsy Res. 2025 Jun 10;15(1):56-69. doi: 10.14581/jer.25006. eCollection 2025 Jun.
2
Does acute stress induced via cold water immersion increase blood THC concentrations in regular cannabis users?通过冷水浸泡诱导的急性应激是否会增加经常吸食大麻者血液中的四氢大麻酚浓度?
Psychopharmacology (Berl). 2025 Jun 14. doi: 10.1007/s00213-025-06833-8.
3
A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats.
一种具有助眠作用的大麻成分:大麻酚及其活性代谢物对大鼠睡眠结构的影响。
Neuropsychopharmacology. 2025 Feb;50(3):586-595. doi: 10.1038/s41386-024-02018-7. Epub 2024 Nov 12.
4
Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA.与MPP-5F-PICA、MMB-5F-PICA和MDMB-5F-PICA相关的蛋白质原氨基酸衍生合成大麻素受体激动剂的合成与功能评估。
RSC Med Chem. 2024 Apr 10;15(6):2063-2079. doi: 10.1039/d3md00758h. eCollection 2024 Jun 19.
5
The Effect of Cannabidiol on Subjective Responses to Endurance Exercise: A Randomised Controlled Trial.大麻二酚对耐力运动主观反应的影响:一项随机对照试验。
Sports Med Open. 2024 May 23;10(1):61. doi: 10.1186/s40798-024-00727-3.
6
Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans.大麻素与健康老龄化:以秀丽隐杆线虫为重点的临床前模型中延长健康寿命和寿命的潜力。
Geroscience. 2024 Dec;46(6):5643-5661. doi: 10.1007/s11357-024-01162-8. Epub 2024 May 2.
7
Ultrasonic or Microwave Modified Continuous Flow Chemistry for the Synthesis of Tetrahydrocannabinol: Observing Effects of Various Solvents and Acids.用于合成四氢大麻酚的超声或微波改性连续流化学:观察各种溶剂和酸的影响。
ACS Omega. 2024 Mar 8;9(11):13191-13199. doi: 10.1021/acsomega.3c09794. eCollection 2024 Mar 19.
8
The Use of Cannabinoids in Pediatric Palliative Care-A Retrospective Single-Center Analysis.大麻素在儿童姑息治疗中的应用——一项回顾性单中心分析
Children (Basel). 2024 Feb 11;11(2):234. doi: 10.3390/children11020234.
9
The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex - A Cannabis-derived Spray.欣百达(盐酸度洛西汀肠溶胶囊)治疗纤维肌痛的有效性和安全性:一项为期 12 周、随机、双盲、安慰剂对照研究
Mini Rev Med Chem. 2024;24(15):1427-1448. doi: 10.2174/0113895575285934240123110158.
10
The Neurotherapeutic Arsenal in : Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects.神经治疗武器库:神经抗炎和神经保护活性的深入了解及潜在伴生效应。
Molecules. 2024 Jan 15;29(2):410. doi: 10.3390/molecules29020410.